| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |